AC
ACHC.US Acadia Healthcare Company Inc
- Market cap
- USD 3.52B
- P/E
- -
- P/B
- 1.78x
- ROE
- 3.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ACHC.US undervalued?
Graham numberThe Graham number of Acadia Healthcare Company Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Acadia Healthcare Company Inc fundamental analysis
No fundamental analysis for Acadia Healthcare Company Inc yet.
Acadia Healthcare Company Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Acadia Healthcare Company Inc
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of…
Full company profileAcadia Healthcare Company Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Acadia Healthcare Company Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.81B | 2.84B | 3.01B | 2.01B | 2.09B | 2.31B | 2.61B | 2.93B | 3.15B | 3.31B | 3.45B |
| Gross Profit | 1.15B | 1.19B | 1.23B | 815M | 2.00B | 2.22B | 2.51B | 683M | 712M | 583M | 604M |
| Operating Income | 445M | 438M | 413M | 662M | 366M | 414M | 468M | 507M | 522M | 388M | 381M |
| EBITDA | 580M | 581M | 386M | 402M | 437M | 459M | 562M | 189M | 608M | -738M | 567M |
| Net Income | 6.14M | 200M | -176M | 109M | -672M | 191M | 273M | -21.7M | 256M | -1.10B | 66.0M |
| EPS | 0.07 | 2.30 | -2.01 | 1.24 | -7.59 | 2.10 | 2.98 | -0.24 | 2.78 | -12 | 0.72 |
| Balance Sheet | |||||||||||
| Total Assets | 6.02B | 6.42B | 6.17B | 6.88B | 6.50B | 4.77B | 4.99B | 5.36B | 5.96B | 5.53B | 5.55B |
| Total Liabilities | 3.86B | 3.85B | 3.84B | 4.37B | 4.60B | 2.19B | 2.09B | 2.47B | 2.77B | 3.39B | 3.30B |
| Shareholders' Equity | 2.17B | 2.57B | 2.33B | 2.51B | 1.90B | 2.52B | 2.81B | 2.78B | 3.07B | 1.95B | 2.02B |
| Cash & Short-term Investments | 57.1M | 67.3M | 50.5M | 99.5M | 379M | 134M | 97.6M | 100M | 76.3M | 133M | 163M |
| Total Debt | 3.29B | 3.24B | 3.19B | 3.26B | 3.26B | 1.64B | 1.53B | 1.51B | 2.09B | 2.65B | 2.50B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 361M | 400M | 414M | 333M | 659M | 374M | 381M | 462M | 130M | 132M | 429M |
| Capital Expenditure | 307M | 274M | 341M | 285M | 217M | 245M | 296M | 424M | 690M | 572M | 221M |
| Free Cash Flow | 54.0M | 125M | 72.6M | 48.2M | 442M | 130M | 84.4M | 38.2M | -561M | -440M | 207M |
| Ratios | |||||||||||
| ROE | 0.3% | 7.8% | -7.5% | 4.3% | -35.4% | 7.6% | 9.7% | -0.8% | 8.3% | -56.6% | 3.3% |
| ROA | 0.1% | 3.1% | -2.8% | 1.6% | -10.3% | 4.0% | 5.5% | -0.4% | 4.3% | -20.0% | 1.2% |
| Net Profit Margin | 0.2% | 7.0% | -5.8% | 5.4% | -32.2% | 8.2% | 10.5% | -0.7% | 8.1% | -33.3% | 1.9% |
| Debt to Equity | 1.52x | 1.26x | 1.37x | 1.30x | 1.71x | 0.65x | 0.54x | 0.54x | 0.68x | 1.36x | 1.24x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Acadia Healthcare Company Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 17.8M | 0.19 | 6.5% |
| 2021 | USD 1.59M | 0.02 | 0.8% |
| 2020 | USD 1.84M | 0.02 | - |
| 2019 | USD 154K | 0.00 | 0.1% |
| 2018 | - | - | - |
| 2017 | USD 682M | 7.83 | 341.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:4 on Nov 1, 2011.
Who owns Acadia Healthcare Company Inc
- Insiders 1.54%
- Institutions 98.46%
- Public & others 0.00%
- Shares outstanding 93.0M
- Free float 91.4M
Top funds holding ACHC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.60M | 6.16% | -0.10% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.98M | 3.28% | +7.03% | Sep 2026 |
| iShares Russell 2000 ETF | 2.39M | 2.63% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 2.10M | 2.31% | +4.39% | Sep 2026 |
| Fidelity Value | 2.06M | 2.27% | 0.00% | Sep 2026 |
| Avantis US Small Cap Value ETF | 2.04M | 2.24% | 0.00% | Oct 2026 |
| DFA U.S. Small Cap Value I | 1.75M | 1.92% | +50.71% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 1.36M | 1.50% | +6.83% | Sep 2026 |
| Fidelity Small Cap Index | 1.02M | 1.12% | +0.28% | Aug 2026 |
| Schwab Fundamental U.S. Small CompanyETF | 946K | 1.04% | 0.00% | Oct 2026 |
| iShares Russell 2000 Value ETF | 887K | 0.98% | 0.00% | Oct 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 849K | 0.93% | -0.05% | Oct 2026 |
| iShares S&P Small-Cap 600 Value ETF | 773K | 0.85% | 0.00% | Oct 2026 |
| DFA U.S. Targeted Value I | 702K | 0.77% | +5.95% | Sep 2026 |
| Vanguard Tax-Managed Small Cap Adm | 682K | 0.75% | -4.62% | Sep 2026 |
| Fidelity Mid Cap Value | 650K | 0.71% | 0.00% | Sep 2026 |
| Invesco Main Street Small Cap R6 | 630K | 0.69% | 0.00% | Sep 2026 |
| Columbia Small Cap Value Discv A | 580K | 0.64% | +0.71% | Sep 2026 |
| Brown Advisory Small-Cap Fdmtl Val Inv | 573K | 0.63% | -1.26% | Sep 2026 |
| Vanguard Russell 2000 ETF | 548K | 0.60% | +2.38% | Sep 2026 |
Top institutions holding ACHC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 15.0M | 16.45% | +27.99% | Jun 2026 |
| Wellington Management Company LLP | 5.73M | 6.30% | -36.89% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 5.37M | 5.91% | +6.09% | Jun 2026 |
| FMR Inc | 5.02M | 5.52% | -26.97% | Jun 2026 |
| Carronade Capital Management LP | 4.76M | 5.24% | +103.77% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 4.70M | 5.17% | +17.06% | Sep 2026 |
| Morgan Stanley - Brokerage Accounts | 4.53M | 4.99% | +0.96% | Jun 2026 |
| Deerfield Management Co | 4.52M | 4.97% | 0.00% | Jun 2026 |
| Farallon Capital Management, L.L.C. | 4.22M | 4.64% | +143.02% | Jun 2026 |
| Abrams Bison Investments, LLC | 4.17M | 4.58% | -4.91% | Jun 2026 |
| UBS Group AG | 4.04M | 4.45% | +42.72% | Jun 2026 |
| Vanguard Capital Management, LLC | 4.01M | 4.41% | -3.47% | Jun 2026 |
| State Street Corp | 3.89M | 4.28% | +20.95% | Jun 2026 |
| Jefferies Financial Group Inc | 3.61M | 3.97% | -0.19% | Jun 2026 |
| American Century Companies Inc | 2.91M | 3.20% | +460.91% | Jun 2026 |
| The Goldman Sachs Group Inc | 2.87M | 3.16% | +28.20% | Jun 2026 |
| Palo Alto Investors, LLC | 2.86M | 3.15% | 0.00% | Jun 2026 |
| Citadel Advisors Llc | 2.67M | 2.93% | -1.87% | Jun 2026 |
| Geode Capital Management, LLC | 2.47M | 2.71% | +48.39% | Jun 2026 |
| Mak Capital One LLC | 2.43M | 2.68% | 0.00% | Jun 2026 |
Acadia Healthcare Company Inc company profile
- Company name
- Acadia Healthcare Company Inc
- Ticker
- ACHC.US
- Exchange
- USA Stocks
- Listed since
- Mar 4, 1994
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 19,000
- Fiscal year end
- December
- Address
- 4020 Aspen Grove Drive, Franklin, TN, United States, 37067
- Phone
- 615 861 6000
- Website
- acadiahealthcare.com
About Acadia Healthcare Company Inc
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Acadia Healthcare Company Inc management
7- Mr. Brian P. Farley Esq., J.D.Executive VP, General Counsel & Secretary · born 1970
- Mr. Timothy SidesSenior Vice President of Operations Finance · born 1978
- Ms. Debra K. OsteenCEO & Director · born 1956
- Mr. David M. DuckworthInterim Chief Financial Officer · born 1980
- Mr. Jason Michael PlagmanVice President of Investor Relations
- Mr. Jeffrey WoodsOperations Group President
- Steve QuigleyGroup President of Specialty Division